(Q34423678)

2 August 2017

Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates (English)

1 reference

2 August 2017

Perez-Pujol S

1

1 reference

2 August 2017

Tonda R

2

1 reference

2 August 2017

Lozano M

3

1 reference

2 August 2017

Fuste B

4

1 reference

2 August 2017

Lopez-Vilchez I

5

1 reference

2 August 2017

Galan AM

6

1 reference

2 August 2017

Li J

7

1 reference

2 August 2017

Goodrich R

8

1 reference

2 August 2017

Escolar G

9

1 reference

2 August 2017

1 June 2005

1 reference

2 August 2017

1 reference

2 August 2017

45

1 reference

2 August 2017

6

1 reference

2 August 2017

911-919

1 reference

Platelet procoagulant activity: physiological significance and mechanisms of exposure

2 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04350.X

Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04350.X

Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04350.X

Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04350.X

The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04350.X

Interaction of platelets with subendothelium in humans treated with aspirin and dipyridamole alone or in combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04350.X

The role of the Baumgartner technique in transfusion medicine: research and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04350.X

Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04350.X

Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04350.X

Functional characteristics of buffy-coat PLTs photochemically treated with amotosalen-HCl for pathogen inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04350.X

Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04350.X

Role of translocases in the generation of phosphatidylserine asymmetry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04350.X

In vitro evaluation of the hemostatic effectiveness of non viable platelet preparations: studies with frozen-thawed, sonicated or lyophilized platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04350.X

10.1111/J.1537-2995.2005.04350.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference